Upperton offers extensive analytical method and validation services as part of our development services as well as stand-alone analytical testing services for projects throughout each stage of the drug life cycle from pre-clinical through to late phase. Our analytical scientists develop and validate methods that support product quality, stability, regulatory compliance and clinical progression.
Our team have access to a wide range of techniques to support your project.
Successful development programmes begin with a thorough understanding of the physio-chemical characteristics of the API. Additionally, it is important to understand any potential stability or excipient incompatibility challenges.
Using a range of techniques including DSC, TGA, XRPD, Microscopy, FTIR, Particle sizing etc, we gain a fundamental understanding and insight into the behaviours of your API to support the development activities required for first in human studies and product development.
Once a product enters clinical development, our dedicated analytics team work with you, and with the cross functional teams in our business. We then transfer, develop and create phase appropriate validation of your analytical methods and performance of QC and release testing. This includes:
We provide fully integrated CDMO services across every stage of the drug product lifecycle.